Sai Life Science Files Draft IPO Papers With SEBI
TPG Group-backed Sai Life Science Ltd. has filed preliminary papers with the market regulator, the Securities and Exchange Board of India, to raise funds via an initial public offering.
The Hyderabad-based global pharmaceutical company's IPO consists of a fresh issue of equity shares worth Rs 800 crore and an offer-for-sale of 6.15 crore shares, according to the draft red herring prospectus.
Sai Quest Syn Pvt. will be the only promoter-selling shareholder, while TPG Asia VII SF Pte Ltd., an affiliate company of the TPG Group, will offload 4.57 crore shares. HBM Private Equity India will be the other shareholder, selling up to 68.62 lakh shares.
Currently, Sai Quest Syn holds a 5.61% stake in the company, TPG owns 39.69% of the shares, and HBM Private Equity India has a 5.5% stake.
Of the IPO proceeds, funds to the tune of Rs 600 crore will be used for debt payment, and a portion will be used for corporate general purposes, the draft papers filed on Friday showed.
Kotak Mahindra Capital Company Ltd., IIFL Securities Ltd., Jefferies India Pvt. and Morgan Stanley India Co. will be the book-running lead managers for the issue.
Sai Life Sciences provides end-to-end services across the drug discovery, development, and manufacturing value chain, from small-molecule new chemical entities to global pharmaceutical innovator companies and biotechnology firms.
As of March 31, 2024, their company's CDMO product portfolio included more than 150 innovator pharmaceutical products, including 38 products that were supplied for the manufacturing of 28 commercial drugs.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.